Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...

This analysis represents Noom’s largest-ever review of the effectiveness of Noom’s GLP-1 Companion app. It shows that members ...

By Amina Niasse NEW YORK, Feb 7 (Reuters) - Companies looking to sell weight-loss drugs directly to consumers, including Novo ...

Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal ...

Glucagon-like peptide agonists, or GLP-1, are seen by many as miracle drugs based on dramatic weight loss.

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes, or another condition. And we expect that number to rise now that ...

If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering ...

By Leah Douglas and Siddhi Mahatole Feb 6 (Reuters) - The U.S. Food and Drug Administration said on Friday it would take ...

By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health on Thursday began offering a much ...

Use this calculator to find out how much fiber you need. Plus, learn about the top sources of fiber, how to increase fiber ...

By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will start offering compounded ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Fear your hairline is pulling back? You’re far ...